The molecular basis of nephrogenic diabetes insipidus

Journal of Molecular Medicine

Volumn 76, Issue 5, 1998, Pages 326-337

  Oksche, Alexander ^a,b   Rosenthal, Walter ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Forsch Inst F Molec Pharmakol

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Aquaporin 2; Diabetes insipidus; Mutation; Signal transduction; Vasopressin V2 receptor

Indexed keywords

AQUAPORIN; VASOPRESSIN V2 RECEPTOR;

ANTIDIURESIS; AUTOSOMAL RECESSIVE INHERITANCE; DIABETES INSIPIDUS; FLUID BALANCE; GENE MUTATION; HOMEOSTASIS; HUMAN; HYPOKALEMIA; MOLECULAR GENETICS; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AQUAPORIN 2; AQUAPORIN 6; AQUAPORINS; DIABETES INSIPIDUS, NEPHROGENIC; GENES, RECESSIVE; HUMANS; ION CHANNELS; LINKAGE (GENETICS); MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, VASOPRESSIN; VASOPRESSINS; X CHROMOSOME;

EID: 0031972413     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050224     Document Type: Review

References (114)

1. Schmale H, Bahnsen U, Richter D (1993) Structure and expression of the vasopressin precursor gene in central diabetes insipidus. Ann New York Acad Sci 689:74-82
2. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis B, Antaramian A, Brabet P, Rosenthal W (1992) Molecular cloning of the receptor for human antidiuretic hormone. Nature 357:333-335
3. Nonoguchi H, Owada A, Kobayashi N, Tukayama M, Terada Y, Koike J, Ujie K, Marumo F, Sakai T, Tomita K (1995) Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest 96:1768-1778
4. Wade JB, Stetson DL, Lewis SA (1981) ADH action: evidence for a membrane shuttle hypothesis. Ann NY Acad Sci 372: 106-117
5. Nielsen S, DiGiovanni SR, Christensen KI, Knepper MA, Harris HW (1993) Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 90:11663-11667
6. Kuwahara M, and Verkman AS (1988) Direct fluorescence meassurement of diffusional water permeability in the vasopressin sensitive kidney collecting tubule. Biophys J 54:587-593
7. Ecelbarger C, Terris J, Frindt G, Echevarria M, Marples D, Nielsen S, Knepper MA (1995) Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol 38:F663-672
8. Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S (1995) Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 269:F775-785
9. Hays RM, Franki N, Simon H, Guo Y (1994) Antidiuretic hormone and exocytosis: lessons from neurosecretion. Am J Physiol 267:C1507-C1524
10. Liebenhoff U, Rosenthal W (1995) Identification of Rab3-, Rab5a- and synaptobrevin-like proteins in a preparation of rat kidney vesicles containing the vasopressin-regulated water channel. FEBS Lett 365:209-213
11. Nielsen S, Marples D, Birn H, Mihtashami M, Dalby NO, Trimble W, Knepper M (1995) Expression of VAMP2-like protein in kidney collecting duct intracellular vesicles: colocalization with aquaporin-2 water channels. J Clin Invest 96: 1834-1844
12. Jo I, Harris HW, Amedt-Raduege AM, Majweski RR, Hammond TG (1995) Rat kidney papilla contains abundant synaptobrevin protein that participates in the fusion of antidiuretic hormone-regulated water channel-containing endosomes in vitro. Proc Natl Acad Sci USA 92:1876-1880
13. Snyder HM, Noland TD, Breyer MD (1992) cAMP-dependent protein kinase mediates hydrosmotic effect of vasopressin in collecting ducts. Am J Physiol 263:C147-C153
14. Star RA, Nonoguchi H, Balaban R, Knepper MA (1988) Calcium and adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J Clin Invest 81:1879-1888
15. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S (1993) Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361:549-552
16. Deen PMT, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, van Os CH, van Oost BA (1994) Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92-95
17. Kuwahara M, Fushimi K, Terada Y, Bai L, Marumo F, Sasaki S (1995) cAMP-dependent phosphorylation stimulates water permeability of aquaporin-collecting duct water channel protein expressed in Xenopus oocytes. J Biol Chem 270:10384-10387
18. Lande MB, Jo I, Zeidel ML, Somers M, Harris HW (1996) Phosphorylation of aquaporin-2 does not alter the membrane water permeability of rat papillary water channel-containing vesicles. J Biol Chem 271:5552-5557
19. Bichet DG, Hendy GN, Lonergan M, Arthus MF, Ligier S, Pausova Z, Kluge R, Zingg H, Saenger P, Oppenheimer E, Hirsch DJ, Gilgenkranzt S, Salles JP, Oberle I, Mandel JL, Gregory MC, Fujiwara M, Morgan K, Scriver CR (1992) X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet 51:1089-1102
20. Ohzeki T, Igarashi T, Okamoto A (1984) Familial cases of congenital nephrogenic diabetes insipidus type II: remarkable increment of urinary adenosine 3′,5′-monophosphate in response to antidiuretic hormone. J Pediatr 104:593-595
21. Bichet DG, Arthus MF, Lonergan M, Balte W, Skorecki K, Nivet H, Robertson G, Oksche A, Rosenthal W, Fujiwara M, Morgan K, Sasaki S (1995) Autosominal dominant and autosomal recessive nephrogenic diabetes insipidus: novel mutations in the AQP-2 gene. J Am Soc Nephrol 6:717
22. Knoers NVAM, van der Heyden H, van der Oost BA, Monnens L, Willems J, Ropers, HH (1988) Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X chromosome. Hum Genet 30:31-38
23. Seibold A, Brabet P, Rosenthal W, Birnbaumer M (1992) Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 51:1078-1083
24. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
25. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy G, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233-235
26. Fujiwara TM, Morgan K, Bichet DG (1995) Molecular biology of diabetes insipidus. Annu Rev Med 46:331-343
27. Rosenthal W, Oksche A, Bichet DG (1997) Two genes - one disease: the molecular basis of congenital nephrogenic diabetes insipidus. Adv Mol Cell Endocrinol (submitted)
28. Oksche A, Dickson J, Schülein R, Seyberth HW, Müller M, Rascher W, Birnbaumer M, Rosenthal W (1994) Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus. Biochem Biophys Res Comm 205:552-557
29. Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W (1996) Vasopressin V2 receptor mutants causing X-linked nephrogenic diabetes insipidus: analysis of expression, processing and function. Mol Pharmacol 50:820-828
30. 2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 46:170-176
31. Wildin RS, Antush MJ, Bennett RL, Schoof JM, Scott CR (1994) Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 55:266-277
32. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genetics 55:278-286
33. Yusua H, Ito M, Oiso Y, Kurokawa M, Watanabe T, Oda Y, Ishizuka T, Tani N, Ito S, Shibata A, Saito H (1994) Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metabol 79:361-365
34. s/adenylyl cyclase system. Mol Endocrinol 8:886-894
35. Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwana A, Antariam A, Birnbaumer M (1993) X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 92:1262-1268
36. Holtzman EJ, Harris HWH, Kolakowski LF, Guay-Woodford LM, Botelho B, Ausiello DA (1993) A molecular defect in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 328:1534-1537
37. Pan Y, Wilson P, Gitschier J (1994) The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J Biol Chem 269:31933-31937
38. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J (1992) Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2:103-106
39. Faa V, Venturo ML, Loche S, Bozzola M, Podda R, Cao A, Rosatelli MC (1994) Mutations in the vasopressin V2 receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Mol Genet 9:1685-1686
40. Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M (1993) Nephrogenic diabetes insipidus: a V2 receptor unable to stimulate adenylyl cyclase. J Biol Chem 268:13030-13033
41. Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T, Inada M (1995) Binding-, intracellular transport-, and biosynthesis-defective mutants of the vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest 96:2043-2050
42. van den Ouweland AMW, Dreesen JCFM, Verdijk MAJ, Knoers NVAM, Monnens LAH, Rocchi M, van Oost BA (1992) Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nature Genet 2:99-102
43. Yokoyama K, Yamaguchi A, Izumi M, Itoh T, Ando A Imai E, Kamada T, Ueda N (1996) A low affinity vasopressin V2 receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 410-414
44. Wenkert D, Merendino JJ Jr, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM (1994) Novel mutations in the V2 vasopressin V2 receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Mol Gen 3:1429-1430
45. Tajima T, Nakae J, Takekoshi Y, Takahashi Y, Yuri K, Nagashima T, Fujieda K (1996) Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 39:522-526
46. 1a vasopressin receptor. J Biol Chem 269:3304-3310
47. Morel A, O'Carroll AM, Brownstein MJ, Lolait SJ (1992) Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356:523-526
48. 1b vasopressin receptor. J Biol Chem 269:27088-27092
49. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button DC, Young III WS, Mezey E, Brownstein MJ (1995) Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 92:6783-6787
50. Saito M, Sugimoto T, Tahara A, Kawashima H (1995) Molecular cloning and characterization of the rat V1b vasopressin receptor: evidence for its expression in extra pituitary tissues. Biochem Biophys Res Comm 212:751-757
51. Fraser CM, Chung FZ, Wang CD, Venter JC (1988) Site-directed mutagenesis of human β-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity binding that is uncoupled from adenylyl cyclase. Proc Natl Acad Sci USA 85:5478-5482
52. Franke RR, Sakmar TP, Graham RM, Khorana HG (1992) Structure and function in rhodopsin. Studies of the interaction between rhodopsin cytoplasmic domain and transducin. J Biol Chem 267:14767-14774
53. Sung CH, Davenport CM, Nathans J (1993) Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. J Biol Chem 268:26645-26649
54. Wess J, Nanavati S, Vogel Z, Maggio R (1993) Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J 12:331-338
55. Schülein R, Liebenhoff U, Müller H, Birnbaumer M, Rosenthal W (1996) Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem J 313:611-616
56. Brüne B, Dimmeler S, Vedia LM, Lapetina EG (1993) Nitric oxide: a signal for ADP-ribosylation of proteins. Life Science 54:61-70
57. Unson CG, Cypess AM, Kim HN, Goldsmith PK, Carruthers CJL, Merrifield RB, Sakmar TP (1995) Characterization of deletion and truncation mutants of the rat glucagon receptor. J Biol Chem 46:27720-27727
58. Schülein R, Rutz C, Rosenthal W (1996) Membrane targeting and determination of transmembrane topology of the human vasopressin V2 receptor. J Biol Chem 271:28844-28852
59. Sasaki S, Fushimi K, Saito H, Saito F, Uchida S, Ishibashi K, Kuwahara M, Ikeuchi T, Inui K, Nakajima K, Watanabe TX, Marumo F (1994) Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest 93:1250-1256
60. Uchida S, Sasaki S, Fushimi K, Marumo F (1994) Isolation of the human aquaporin-CD gene. J Biol Chem 269:23451-23455
61. van Lieburg AF, Verdijk MAJ, Knoers NVAM, van Essen AJ, Proesmans W, Mallmann R, Monnens LAH, van Oost BA, van Os CH, Deen PMT (1994) Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648-652
62. Oksche A, Möller A, Dickson J, Rosendahl W, Rascher W, Rosenthal W (1996) Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Human Genet 98:587-589
63. Mulders SM, Knoers NVAM, van Lieburg AF, Monnens LAH, Leumann E, Wuhl E, Schober E, Rjiss JPL, van Os CH, Deen PMT (1997) New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 8:242-248
64. Hochberg Z, van Lieburg A, Even L, Brenner B, Lanir N, van Oost BA, Knoers NVAM (1997) Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. J Clin Endocrinol Metabol 82:686-689
65. Jung JS, Preston GM, Smith BL, Guggino WB, Agre P (1994) Molecular structure of the water channel through aquaporin CHIP. The hourglass model. J Biol Chem 269:14648-14654
66. Deen PMT, Croes H, van Aubel RAMH, Ginsel LA, van Os CH (1995) Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95:2291-2296
67. Kanno K, Sasaki S, Hirata Y, Ishikawa SE, Fushimi K, Nakanishi S, Bichet DG, Marumo F (1995) Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 332:1540-1576
68. Deen PMT, van Aubel RAMH, van Lieburg AF, van Os CH (1996) Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol 7:836-841
69. Hoeckstra JA, van Lieburg AF, Monnens LAH, Hulstijn-Dirkmaat, Knoers NVAM (1996) Cognitive and psychological functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Gen 61:81-88
70. van Lieburg AF, Verdijk MAJ, Schoute F, Ligtenberg MJL, van Oost BA, Waldhauser F, Dobner M, Monnens LAH, Knoers NVAM (1995) Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 96:70-78
71. Moses AM, Sangani G, Miller JL (1995) Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metabol 80:1184-1186
72. Ergezinger K, Oksche A, Möller A, Schwab KO, Rosenthal W (1996) Variable phenotypes in females with X-linked nephrogenic diabetes insipidus. Hormon Res 46 [Suppl]2:112
73. Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K (1985) Congenital hypokalemia with hypercalcuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107:694-701
74. Bichet DG, Razi M, Longergan M, Arthus MF, Vassiliki P, Kortas C, Barjon JN (1988) Hemodynamic and coagulation responses to 1-desamino-[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318:881-887
75. Knoers NVAM, Monnens LAH (1991) A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr 150:370-373
76. Booth F, Allington MJ, Cederhom-Williams SA (1987) An in vitro model for the study of acute release of von Willehrand factor from human endothelial cells. Br J Haematol 67:71-78
77. Barnhart MI, Chen S, Lusher JM (1983) DDAVP: does the drug have a direct effect on the vessel wall? Thromb Res 31:239-253
78. Manucci PM, Aberg M, Nilsson IM and Robertson B (1975) Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 30:81-93
79. Breit SN and Green I (1988) Modulation of endothelial cell synthesis of von Willebrand factor by mononuclear cell products. Haemostasis 18:137-145
80. Hashemi S, Tackaberry ES, Palmer DS, Rock G and Ganz PR (1990) DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells. Biochim et Biophys Acta 102:63-70
81. Liard JF (1994) L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs. Am J Physiol 266:H99-H106
82. Aki Y, Tamaki T, Kiyomoto H, He H Yoshida H Iwao H, Abe Y (1994) Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilatation. J Cardiovas Pharmacol 23:331-336
83. Tamaki T, Kiyomoto K, He H, Tomohiro A, Nishiyama A, Aki Y, Kimura S, Abe Y (1996) Vasodilatation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int 49:722-729
84. Kato Y, Igarashi N, Hirasawa A, Tsujimoto G, Kobayashi M (1995) Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain. Differentiation 59:163-169
85. Fay MJ, Du J, Yu X, North WG (1996) Evidence for expression of vasopressin V2 receptor mRNA in human lung. Peptides 17:477-481
86. Boton R, Gaviria M, Batlle DC (1987) Prevalence, pathogenesis and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10:329-345
87. Ramsey TA, Cox M (1982) Lithium and the kidney: a review. Am J Psychiatr 139:443-449
88. Bendz H (1983) Kidney function in lithium-treated patients. A literature survey. Acta Psychiatr Scand 68:303-324
89. Hetmar O, Brun C, Clemmensen L, Ladefoged J, Larsen S, Rafaelsen OJ (1987) Lithium: long-term effects on the kidney: structural changes. J Psychiatr Res 21:279-288
90. Yamaki M, Kusano E, Tetsuka T, Takeda S, Homma S, Murayama N, Asano Y (1991) Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats. Am J Physiol 261:F505-511
91. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S (1995) Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95:1838-1845
92. Kim JK, Summer SN, Berl T (1983) The cyclic AMP system in the inner medullary collecting duct of the potassium-depleted rat. Kidney Int 26:384-391
93. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S (1996) Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 97:1960-1968
94. Mork A and Geisler A (1995) A comparative study on the effects of tetracyclins and lithium on the cyclic AMP second messenger system in rat brain. Prog Neuro Psycho Biol Psych 19:157-169
95. Teitelbaum I and McGuinness S (1995) Vasopressin resistance in chronic renal failure. J Clin Invest 96:378-385
96. Fine LG, Schlondorff D, Trizna W, Gilbert RM and Bricker NS (1978) Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin. J Clin Invest 61:1519-1527
97. Alon U, Chan JC (1985) Hydrochlorothiazide-amiloride in the treatment of congenital diabetes insipidus. Am J Nephrol 5:9-13
98. Torikai S, Kurokawa K (1983) Effect of PGE, on vasopressin-dependent cell cAMP in isolated single nephron segments. Am J Physiol 245:F58-66
99. Higashihara E, Stokes JB, Kokko JP, Campbell WB, DuBose TD Jr (1979) Cortical and papillary micropuncture examination of chloride transport in segments of the rat kidney during inhibition of prostaglandin production. Possible role for prostaglandins in the chloruresis of acute volume expansion. J Clin Invest 64:1277-1287
100. Stokes JB (1981) Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol 240:F471-480
101. Wuthrich RP, Vallotton MB (1986) Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells. Am J Physiol 251:F499-505
102. 2 in nephrogenic diabetes insipidus: effect of inhibition of prostaglandin synthesis by indomethacin. J Pediatr 97:476-478
103. Blachar Y, Zadik Z, Shemesh M, Kaplan BS, Levin S (1980) The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus. Int J Pediatr Nephrol 1:48-52
104. Höhler T, Teuber G, Wanitschke R, Meyer zum Büschenfelde KH (1994) Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus. Clin Invest 72:769-771
105. Kosten TR, Forrest JN (1986) Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatr 143:1563-1568
106. Hironka K, Makino H, Ogura T, Ota Z (1995) Renal histology in a patient with nephrogenic diabetes insipidus. Nephron 71:224-226
107. Ishii H, Mizuno K, Niimura S, Haga H, Takahashi M, Watanabe Y, Tanaka K, Ogata M, Tanaka N, Fukuchi S (1993) Congenital nephrogenic diabetes insipidus in adult. Intern Med 32:133-138
108. Colley NJ, Cassill JA, Baker EK, Zuker CS (1995) Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc Natl Acad Sci USA 92:3070-3074
109. - channel is functional when retained in endoplasmic reticulum of mam-malian cells. J Biol Chem 270:12347-12350
110. Ward CL, Omura S, Kopito R (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-127
111. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240:1310-1316
112. Ridge KD, Lee SSJ, Yao LL (1995) In vivo assembly of rhodopsin from expressed polypeptide fragments. Proc Natl Acad Sci USA 92:3204-3208
113. Maggio R, Vogel Z, Wess J (1993) Reconstitution of functional muscarinic receptors by coexpression of amino and carboxyl terminal receptor fragments. FEBS Lett 319:195-200
114. Schöneberg T, Yun J, Wenkert D, Wess J (1996) Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15:1283-1291